MEDS - TRxADE HEALTH, Inc. Business Value

Public company logo of trxadehealth.com (MEDS)

TRxADE HEALTH, Inc. (MEDS) is implementing software robots for predictive drug ordering and automated price analysis. Business revenues are based on commissions from independent pharmacy purchases made via the TRxADE marketplace. The price action for the company shown on this chart, where the Enterprise Value is 40.21, confirms the model's resilience: the deep integration of IT tools into client finances creates a virtually continuous payment stream.

Enterprise Value: TRxADE (MEDS) for 07/23/2026 - 10/29/2026

TRxADE HEALTH, Inc. - analytical breakdowns and key metrics (MEDS)

- market value and analyst target forecast:
Market Price TRxADE HEALTH Inc|MEDS - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization TRxADE HEALTH|MEDS - Total Company Value
- balance sheet net asset value indicators:
Net Assets per Share TRxADE HEALTH|MEDS - Book Capitalization|Market Capitalization to Book Value trxadehealth.com|MEDS - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital TRxADE HEALTH, Inc.|MEDS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital trxadehealth.com|MEDS - Company Debts|Debt to Book Value TRxADE HEALTH|MEDS - Company Long-Term Debts|Short-Term Debt TRxADE HEALTH
Analysis of all company metrics:MEDS - TRxADE HEALTH Inc
Product sample of trxadehealth.com

Amidst the radical transformation of the TRxADE HEALTH (MEDS) logistics model, the aggregate enterprise value allows investors to filter out the volatility of current financial results. This indicator determines the actual acquisition cost of the asset by summing market capitalization with debt obligations and subtracting available cash, providing the investor with an objective view of the company's scale regardless of its borrowing structure.

Who TRxADE HEALTH, Inc. competes with

Veeva Systems (VEEV) - Total Enterprise Value|Doximity Corp - Enterprise Value|HQY (HealthEquity Building) - Business Value|Waystar Holding Corp. (WAY) - Total Company Value|CRVL - Company Buyout Price|PRVA (Privia Health) - Enterprise Value|Huron Consulting Group Inc. (HURN) - Company Buyout Price|Real Price to Acquire Entire Company CERT (Certara Corp)|Aggregate Business Value OMCL|GoodRx Holdings, Inc. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SDGR|PHR - Total Company Value|Omada Health, Inc. (OMDA) - Real Price to Acquire Entire Company|EVH: Enterprise Value|Total Enterprise Value HealthStream Learning (HSTM)|DH (Definitive Healthcare) - Enterprise Value|Business Value CCSI (consensus.com)|Real Price to Acquire Entire Company AGL (agilon health)|Aggregate Business Value ABSI|Total Company Value SoYoung SY|Value Adjusted for Debt and Cash NRC|SPOK: Real Price to Acquire Entire Company|OPRX (optimizerx.com) - Business Value|TBRG: Enterprise Value|Simulations Plus Inc (SLP) - Enterprise Value|SOPH (Sophia Genetics) - Enterprise Value|Business Value HCAT (Health Catalyst Inc)|Enterprise Value CCLD|RSSS - Total Enterprise Value|DLH Holdings - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash ONMD|Scienture Holdings Inc. - Enterprise Value|Value Adjusted for Debt and Cash HCTI (Healthcare Triangle Corporation)|ISPC: Enterprise Value|Total Enterprise Value Bullfrog AI (BFRG)|WORX (SCWorx) - Enterprise Value|Enterprise Value MSP Recovery Inc.|Total Company Value iCoreConnect Inc. (ICCT)|Total Company Value ORGS (Orgenesis Corporation)|R1 RCM - Real Price to Acquire Entire Company|Aggregate Business Value SHCR (sharecare.com)|Streamline Health - Enterprise Value|Value Adjusted for Debt and Cash SYRA (Syra Health Corp)|AMEH (apollomed.net) - Real Price to Acquire Entire Company|Model N Corporation - Value Adjusted for Debt and Cash|NXGN (NextGen Healthcare) - Enterprise Value